Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00588770 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00588770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 8, 2008
Completion date
February 20, 2027
Enrollment
403 (actual)
Sites
779

Conditions

As the registry lists them; a condition with its own page is linked.

neck squamous cell carcinoma of unknown primary, recurrent hypopharyngeal squamous cell carcinoma, recurrent laryngeal squamous cell carcinoma, recurrent laryngeal verrucous carcinoma, recurrent lip and oral cavity squamous cell carcinoma, recurrent neck squamous cell carcinoma of unknown primary, recurrent oral cavity verrucous carcinoma, recurrent oropharyngeal squamous cell carcinoma, recurrent salivary gland carcinoma, recurrent sinonasal squamous cell carcinoma, salivary gland squamous cell carcinoma, stage iv hypopharyngeal squamous cell carcinoma ajcc v7, stage iv major salivary gland cancer ajcc v7, stage iva laryngeal squamous cell carcinoma ajcc v7, stage iva laryngeal verrucous carcinoma ajcc v7, stage iva lip and oral cavity squamous cell carcinoma ajcc v6 and v7, stage iva major salivary gland cancer ajcc v7, stage iva oral cavity cancer ajcc v6 and v7, stage iva oropharyngeal squamous cell carcinoma ajcc v7, stage iva sinonasal squamous cell carcinoma ajcc v7, stage ivb laryngeal squamous cell carcinoma ajcc v7, stage ivb laryngeal verrucous carcinoma ajcc v7, stage ivb lip and oral cavity squamous cell carcinoma ajcc v6 and v7, stage ivb major salivary gland cancer ajcc v7, stage ivb oral cavity cancer ajcc v6 and v7, stage ivb oropharyngeal squamous cell carcinoma ajcc v7, stage ivb sinonasal squamous cell carcinoma ajcc v7, stage ivc laryngeal squamous cell carcinoma ajcc v7, stage ivc laryngeal verrucous carcinoma ajcc v7, stage ivc lip and oral cavity squamous cell carcinoma ajcc v6 and v7, stage ivc major salivary gland cancer ajcc v7, stage ivc oral cavity cancer ajcc v6 and v7, stage ivc oropharyngeal squamous cell carcinoma ajcc v7, stage ivc sinonasal squamous cell carcinoma ajcc v7, tongue carcinoma